Article
Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production.
Molecular and cellular endocrinology - 12 Feb 2004
Nicod Jérôme, Dick Bernhard, Frey Felix J, Ferrari Paolo
Abstract excerpt
BACKGROUND: In patients with glucocorticoid remediable aldosteronism (GRA), a rare hypertensive disorder caused by the presence of a chimeric aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) gene, high level of urinary 18-hydroxycortisol (18OHF) excretion are observed. In some patients with hypertension, increased urinary 18OHF secretion is also found in the absence of the hybrid CYP11B1/CYP11B2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
